DrugDashboards

Paroxetine

paroxetine hydrochloride · PAROXETINE HYDROCHLORIDE ANHYDROUS 30 mg/1 · Tablet, Film Coated · Oral · Apotex Corp.

NDC 60505-0084-01 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 13% over the past year, to $0.0940 per unit. The brand (Paxil) runs $10.81 per unit — 171× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0940per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.0940per TABweighted avg manufacturer price $0.0443 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Nov 2013Sep 2026$0.094
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.82
#90 count
$8.46

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$6,450
560 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for paroxetine hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA075356
TE code
AB
Approval date
Jul 30, 2003
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingNov 1, 2023
    Apotex Corp. — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
  • Class II · OngoingNov 1, 2023
    Apotex Corp. — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
  • Class II · OngoingNov 1, 2023
    Apotex Corp. — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
  • Class II · OngoingNov 1, 2023
    Apotex Corp. — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

Manufacturers of paroxetine hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Aphena Pharma Solutions - Tennessee, LLCPAROXETINE HYDROCHLORIDE ANHYDROUS 40 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 20 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 10 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCPAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Apotex CorpPAROXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.PAROXETINE HYDROCHLORIDE ANHYDROUS 10 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.PAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.PAROXETINE HYDROCHLORIDE ANHYDROUS 40 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.PAROXETINE HYDROCHLORIDE ANHYDROUS 30 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 30 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackPAROXETINE HYDROCHLORIDE HEMIHYDRATE 30 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCPAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 10 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 30 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 40 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPAROXETINE HYDROCHLORIDE ANHYDROUS 10 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsPAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 20 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 30 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 40 mg/1Jul 15, 2026Sep 2, 2026
NorthStar Rx LLCPAROXETINE HYDROCHLORIDE HEMIHYDRATE 10 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Oxford Pharmaceuticals, LLCPAROXETINE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals, IncPAROXETINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals, IncPAROXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 30 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.PAROXETINE HYDROCHLORIDE ANHYDROUS 40 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedPAROXETINE HYDROCHLORIDE ANHYDROUS 40 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedPAROXETINE HYDROCHLORIDE ANHYDROUS 10 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedPAROXETINE HYDROCHLORIDE ANHYDROUS 20 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedPAROXETINE HYDROCHLORIDE ANHYDROUS 30 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedPAROXETINE HYDROCHLORIDE HEMIHYDRATE 40 mg/1Jul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Paroxetine — NDC 60505-0084-01," retrieved September 3, 2026, https://drugdashboards.com/drug/60505008401.

Free to cite with attribution — see how the data is put together.